Electronic cigarettes have surged in popularity. Some view e-cigarettes as a less harmful alternative to traditional cigarettes and a potential harm reduction strategy. Others worry about their addictive potential and see them as a setback in our quest for a tobacco-free society.
Read More
Asthma and chronic obstructive pulmonary disease (COPD) are underdiagnosed. Is there an effective way to capture undiagnosed symptomatic patients and route them for appropriate management of respiratory symptoms?
Read More
Despite advances in the management of acute myocardial infarction (MI), up to 38% of patients will experience signs of heart failure and many will have a reduced left ventricular ejection fraction. Sodium-glucose cotransporter 2 inhibitors have well-documented cardiovascular benefits; however, data about their usefulness after an acute MI are limited.
Read More
One of the most debilitating aspects of dementia is the prevalence of behavioral and psychological symptoms that impact nearly 90% of patients. To combat them, antipsychotic medications are often prescribed, but not without possibly harmful consequences. A new study sheds new light on how detrimental these consequences are.
Read More
Of the nearly 70% of current smokers who want to quit smoking, only about 7.5% succeed. Many patients make multiple quit attempts (average about six) before they achieve long-term success.
Read More
The patient was refered to the clinical pharmacist for management and follow of dyslipidemia. The patient has CAD and is post-MI but not currently taking a statin.
Read More
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are one of the established treatments used to slow the progression of CKD and improve outcomes. Could perhaps the glucagon-like peptide 1 (GLP-1) receptor agonists provide similar, additive, or different benefits in patients with CKD?
Read More
Over the last several decades, the popularity of cannabis (aka marijuana, weed) has increased significantly, and the recognition of medical benefits is evolving. Cannabis is often celebrated in popular culture and its use among young adults and pregnant women is increasing steadily.
Read More
New evidence from the FRAIL-AF trial suggests that some of our most vulnerable older adults should be maintained on a vitamin K antagonist (like warfarin), rather than switched to a DOAC.
Read More
The patient is being seen for routine follow-up in the heart failure … but has multiple comorbidities with potentially overlapping symptoms and hypotension limiting renal
dialysis sessions.
Direct oral anticoagulants (DOACs) are the standard of care for stroke prevention in most patients with nonvalvular atrial fibrillation (NVAF). Data on the safety and efficacy of DOACS in patients with obesity are limited and, at times, contradictory.
Read More
Patients with diabetes mellitus are at increased risk of dementia; therefore, data about the possible impact of medications on the development of dementia is critical. Metformin has been the most frequently prescribed medication for type 2 diabetes. Does metformin impact the risk of dementia?
Read More
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.
Loading ...